Welcome to our dedicated page for Datavault AI SEC filings (Ticker: DVLT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Datavault AI Inc. filings document material-event reporting for a Nasdaq-listed technology company with common stock registered under the symbol DVLT. Recent Form 8-K disclosures cover material definitive agreements, operating and financial results, Regulation FD communications, registered securities information and capital-structure actions involving common stock, warrants and token distributions.
The filing record also includes disclosures on shareholder voting matters, governance matters, Nasdaq continued-listing compliance, and agreements that use Datavault AI shares as consideration. These documents describe how the company's data monetization, credentialing, digital engagement and real-world asset tokenization business is reflected in formal securities-law reporting, including financing, security-structure and material-event categories.
Datavault AI Inc. (DVLT) reported an insider tax-related stock sale by its Chief Financial Officer and director. On 11/21/2025, 28,594 shares of Datavault AI common stock were sold in the open market at a weighted average price of $2.4396 per share, with individual trade prices ranging from $2.355 to $2.495. The shares were sold by the issuer on behalf of the reporting person to satisfy tax obligations arising from the vesting of equity awards and were not a discretionary transaction by the insider. After this transaction, the reporting person beneficially owned 1,089,071 shares of Datavault AI common stock, held directly.
Datavault AI Inc. (DVLT) Chief Executive Officer Nathaniel Bradley reported tax-related sales of company stock. On 11/21/2025, 20,493 shares of common stock were sold at a weighted average price of $2.4396 per share to cover tax obligations from vesting equity awards, described as a non-discretionary transaction made by the issuer on his behalf. Following this, Bradley directly beneficially owned 4,715,477 shares of common stock and indirectly owned 12,109,002 shares through EOS Technology Holdings Inc. In a related transaction for tax withholding, 7,315 shares were sold on behalf of his spouse at the same average price, after which 3,168,503 shares were held indirectly through the spouse.
Datavault AI Inc. (DVLT) reported an insider transaction by its Chief Accounting Officer and VP of Finance, Stanley Mbugua. On 11/21/2025, 8,219 shares of common stock were sold in open-market transactions at a weighted average price of $2.4396 per share, with individual trades ranging from $2.355 to $2.495. The sale was made by the company on behalf of the officer solely to cover tax obligations arising from the vesting of equity awards and was not a discretionary trade by the officer. Following these transactions, the officer beneficially owns 316,199 shares of Datavault AI common stock.
Datavault AI Inc. is registering 13,744,806 shares of common stock on Form S-8 for issuance under its 2018 Long-Term Stock Incentive Plan, pursuant to the plan’s evergreen provision. This filing allows the company to issue additional shares under the existing equity incentive framework without a new shareholder approval cycle for each incremental increase. The company incorporates by reference its latest Annual Report on Form 10-K, recent Quarterly Reports on Form 10-Q, numerous Current Reports on Form 8-K and the description of its common stock. Datavault AI describes broad indemnification and insurance protections for its directors and officers under Delaware law and its bylaws and lists the legal opinions, consents and governing plan documents as exhibits.
Datavault AI Inc. has filed a Form S-8 to register an aggregate of 735,000 shares of its common stock, par value $0.0001 per share, for issuance under its 2018 Long-Term Stock Incentive Plan. The shares are being added to the plan pursuant to the plan’s “evergreen” provision described in Section 5.A, which allows additional shares to become available for awards over time. The filing also restates the company’s indemnification protections for directors and officers under Delaware law, supported by bylaws, indemnification agreements and insurance coverage.
Datavault AI Inc. (DVLT) filed its Q3 2025 10‑Q, showing higher revenue but wider losses. Revenue reached $2.9M for Q3 2025 (vs. $1.2M a year ago), driven mainly by the new Live Events business, while gross profit was $0.1M.
Operating expenses were $14.9M in Q3, leading to a loss from operations of $(14.8)M. Below the line, fair value changes on notes and debt activity weighed on results, and the quarter closed with a net loss of $(33.0)M. For the nine months, revenue was $5.3M and net loss was $(79.7)M.
The May 2025 acquisition of CompuSystems, Inc.’s assets added scale to services; intangibles were $97.5M and goodwill $19.1M as of September 30, 2025. Cash and equivalents were $1.7M, crypto assets $8.1M, total assets $138.7M, total liabilities $39.2M, and stockholders’ equity $99.5M. Q3 revenue mix: Live Events $2.2M, Components $0.6M, Consumer Audio $0.05M. Shares outstanding were 217,201,387 as of September 30, 2025; 285,217,148 as of November 11, 2025.
The company regained Nasdaq minimum bid compliance on October 10, 2025. Contract liabilities were $2.2M, reflecting upfront billings for services.
Datavault AI (DVLT) entered a new office lease for approximately 23,037 rentable square feet on the 24th floor of One Commerce Square, 2005 Market Street, Philadelphia. The lease runs for 60 months and sets five fixed-rent periods, starting near $48,000 per month, with increases of about 2.5% each period.
The company will also pay utilities and Operating Expenses, including maintenance, operations, repairs, replacements, and taxes.
Datavault AI Inc. (DVLT) entered a major licensing deal with Scilex Holding Company. The agreement grants Scilex a worldwide, exclusive, non‑transferable license, with sublicensing rights, to use Datavault’s patented data platform technologies and related know‑how in biotechnology, biopharma, genetic, diagnostic, and data‑related markets covering generation, storage, analysis, tokenization, and exchange of DNA/genetic data.
Economics are sizable and multi‑layered: Scilex will pay a non‑refundable $10,000,000 license fee in four equal $2,500,000 quarterly installments beginning on December 31, 2025, plus potential milestones of up to $2,550,000,000 tied to net sales, and a 5% royalty on net sales during the royalty term. The license runs until the underlying patents expire, then converts to a perpetual, irrevocable, non‑exclusive, royalty‑free license. The agreement can terminate for insolvency, material breach, uncured missed payments within 15 days, or if annual royalty payments of at least $1,000,000 are not achieved and maintained after 24 months from the agreement date. The parties provided customary representations, warranties, and reciprocal indemnities.
Datavault AI Inc. (DVLT) entered into a definitive agreement to acquire API Media Innovations Inc. for cash consideration of $14,000,000. The Stock Purchase Agreement covers the purchase of all outstanding API Media shares and includes customary representations, warranties, covenants, and closing conditions.
The agreement may be terminated by mutual consent or by either party after the Outside Date of December 5, 2025 if closing has not occurred, subject to a no‑breach provision. It may also be terminated upon a final, non‑appealable governmental order prohibiting the deal or for uncured breaches after ten days’ written notice.
Datavault AI Inc. (DVLT) entered into a definitive agreement to acquire API Media Innovations Inc. for cash consideration of $14,000,000. The Stock Purchase Agreement covers the purchase of all outstanding API Media shares and includes customary representations, warranties, covenants, and closing conditions.
The agreement may be terminated by mutual consent or by either party after the Outside Date of December 5, 2025 if closing has not occurred, subject to a no‑breach provision. It may also be terminated upon a final, non‑appealable governmental order prohibiting the deal or for uncured breaches after ten days’ written notice.